Risk Estimation for a Malignant Transformation of Oral Lesions by S100A7 and Doc-1 Gene Expression

REFERENCES

• Silverman S, Jr. Oral Cancer, 4th edition. Hamilton, BC: Decker, 1998; 25–33.
   Google Scholar
• Chambers MS, Jacob RF. How carcinogens cause cancer. Tex Dent J 1994;111:13–19.
   Google Scholar
• Wenghoefer M, Pesch B, Harth V, Broede P, Fronhoffs S, Landt O, Brüning T, Abel J, Bolt HM, Herberhold C, Vetter H, Ko YD. Association between head and neck cancer and microsomal epoxide hydrolase genotypes. Arch Toxicol 2003;77(1):37–41.
   PubMed Web of Science ®Google Scholar
• Pindborg JJ. Oral Cancer and Precancer. Bristol: John Wright and Sons, 1980.
   Google Scholar
• Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T, Wong DT. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 2002;38(3):235–243.
   PubMed Web of Science ®Google Scholar
• Bouquot JE. Epidemiology. In Pathology of the Head and Neck, DG Gnepp (eds.). New York, NY: Churchill Livingstone, 1987, 263–314.
   Google Scholar
• Bouquot JE. Reviewing oral leukoplakia-clinical concepts for the 1990s. J Amer Dent Assoc 1991;122:80–82.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg 2008a;37(7):660–663.
   PubMed Web of Science ®Google Scholar
• SEER. Surveillance, Epidemiology, and End Results-Brochure. (Program of the National Cancer Institute, United States of America, www.cancer.gov, 2005.
   Google Scholar
• Axell, T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odont Revy 1976;27(suppl. 26):1–103.
   PubMedGoogle Scholar
• Bouquot JE, Gundlach KKH. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol 1986;62:284–291.
   PubMedGoogle Scholar
• Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36(10):575–580.
   PubMed Web of Science ®Google Scholar
• Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6(2):147–160.
   PubMedGoogle Scholar
• Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich RH, Martini M, Bergé S, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(3):351–356.
   PubMed Web of Science ®Google Scholar
• Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100A7 expression and missing DOC-1 downregulation characterize irritation fibromas of the oral cavity and might counteract malignant transformation. J Craniofac Surg 2011;22(1):100–104.
   PubMed Web of Science ®Google Scholar
• Dayan D, Bodner L, Hammel I, Wolman M. Histochemical characterization of collagen fibers in fibrous overgrowth (irritation fibroma) of the oral mucosa: effect of age and duration of lesion. Arch Gerontol Geriatr 1994;18(1):53–57.
   PubMed Web of Science ®Google Scholar
• Kim ST, Kim HJ, Park IS, Park SW, Kim WH, Kim YM. Chronic, reactive conditions of the oral cavity simulating mucosal carcinomas: CT and MR imaging findings with pathologic correlation in five patients. Clin Imaging 2005;29(6):406–411.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, McBride. p12DOC-1, a growth suppressor, associates with DNA polymerase a/primase. FASEB J 2000;14:1318–1324.
   PubMed Web of Science ®Google Scholar
• Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T. p12DOC-1 is a novel CDK2-associated protein. Mol Cell *** Biol 2001a;20:6300–6307.
   Web of Science ®Google Scholar
• Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY. Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 1995;9:1362–1370.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J. Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene doc-1. J Biol Chem 1998;273:6704–6709.
   PubMed Web of Science ®Google Scholar
• Shintani S, Mihara M, Terakado N, Nakahara Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, Tsuji T, Wong DT. Reduction of p12DOC-1 expression is a negative prognostic indicator in head and neck/oral cancer. Clin Cancer Res 2001b;7:2776–2782.
   PubMed Web of Science ®Google Scholar
• Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calciumdependent and -independent interactions of the S100 protein family. Biochem J 2006;396:201–214.
   PubMed Web of Science ®Google Scholar
• Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 2005;280:29186–29193.
   PubMed Web of Science ®Google Scholar
• Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998;30:567–571.
   PubMed Web of Science ®Google Scholar
• Emberley ED, Murphy LC, Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res 2004;6:153–159.
   PubMed Web of Science ®Google Scholar
• Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002;7: d1356–1368.
   PubMed Web of Science ®Google Scholar
• Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003;60:540–551.
   PubMed Web of Science ®Google Scholar
• Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001;33:637–668.
   PubMed Web of Science ®Google Scholar
• Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, S100 proteins in the epidermis. J Invest Dermatol 2004;123:23–33.
   PubMed Web of Science ®Google Scholar
• Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K. Molecular cloning, occurrence, and expression of a novel partially secreted protein ‘‘psoriasin’’, that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991;97:701–712.
   PubMed Web of Science ®Google Scholar
• Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003;51:675–685.
   PubMed Web of Science ®Google Scholar
• El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002;62:6823–6826.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao Q, Chen Y, Wang Y, Gao S, (2008) Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax 63:352–359.
   PubMed Web of Science ®Google Scholar
• Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007;133: 253–261.
   PubMed Web of Science ®Google Scholar
• Ji J, Zhao L, Wang X, Zhou C, Ding F. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004;130:480–486.
   PubMed Web of Science ®Google Scholar
• Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996;155:2105–2112.
   PubMed Web of Science ®Google Scholar
• Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999;155:2057–2066.
   PubMed Web of Science ®Google Scholar
• Tripathi SC, Matta A, Kaur J, Grigull J, Chauhan SS, Thakar A, Shukla NK, Duggal R, DattaGupta S, Ralhan R, Siu KW. Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One 2010;5(8):e11939.
   PubMedGoogle Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002–2007.
   Web of Science ®Google Scholar
• Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol 2008.
   PubMed Web of Science ®Google Scholar
• Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest 2009;27(5):575–581.
   PubMed Web of Science ®Google Scholar